Martin Shkreli, the controversial ex-drug executive now facing federal criminal charges, nearly doubled the money he invested in KaloBios, the drug company he briefly ran last fall.
Shkreli started buying shares of KaloBios (KBIO) last November when it was a penny stock, about a...
Read More.......
No comments:
Post a Comment